Orthopedic surgical robotics co opens its doors; files with FDA
The ROBODOC has been very well received by hospitals and orthopedic surgeons from both academic institutions and private hospitals in Europe and Asia, including Japan, Korea and India. The system has already been approved by Korea's regulatory agency, KFDA.
"CMI's mission is to make computer assisted surgery a gold standard for all major orthopedic surgeries by the year 2012 and to be the world leader in this market segment," said Dr. Ramesh Trivedi, President and CEO.
"We have already received funding from Novatrix and have been assured of future funding to accomplish our goals," said Trivedi. "We are actively recruiting highly qualified and experienced staff to rapidly grow the business."
Novatrix Biomedical, Inc., based in Southern California, develops proprietary technologies in the drug delivery field. "We firmly believe that CMI has the right strategy, a well thought out plan and a highly experienced team in place to be a dominant player in the orthopedic surgical robotics field," said Dr. Soon Kap Hahn, President and CEO of Novatrix Biomedical.